2009China Practical MedicineRequires access

Comparison study of aripiprazole and haloperidol in treatment of schizophrenia

Liu Chuan-ju

Open publisher page 0 citations

Abstract

Objective To compare the efficacy and safety of aripiprazole and haloperidol in treatment of schizophrenia.Methods Antipsychotic efficacy was assessed by positive and negative symptom scale(PANSS)and clinical global impressions-secerity of illness rating scale of illness rating scale(CGL-SI),antipsychotic side effect was assessed by treatment emergent symptom scale(TESS),and rating scale for extrapyrarnidal side effects(RSESE)in 35 patients treated by aripiprazole(aripiprazole group)and 36 patients treated by haloperidol(hakioerudol group)for six weeks.Results The efficacy was similar in two groups.The reduction of total negative score in patients of aripiprazole group was significantly higher than that in haloperidol group after 4 and 6 weeks.Patients in aripiprazole group had significantly less side effects.Conclusion Aripiprazole is an effective and safe antipsychotic.

About this research paper

What this paper is about

Objective To compare the efficacy and safety of aripiprazole and haloperidol in treatment of schizophrenia.Methods Antipsychotic efficacy was assessed by positive and negative symptom scale(PANSS)and clinical global impressions-secerity of illness rating scale of illness rating scale(CGL-SI),antipsychotic side effect was assessed by treatment emergent symptom scale(TESS),and rating scale for extrapyrarnidal side effects(RSESE)in 35 patients treated by aripiprazole(aripiprazole group)and 36 patients treated by haloperidol(hakioerudol group)for six weeks.Results The efficacy was similar in two groups.The reduction of total negative score in patients of aripiprazole group was significantly higher than that in haloperidol group after 4 and 6 weeks.Patients in aripiprazole group had significantly less side effects.Conclusion Aripiprazole is an effective and safe antipsychotic.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the efficacy and safety of aripiprazole and haloperidol in treatment of schizophrenia.Methods Antipsychotic efficacy was assessed by positive and negative symptom scale(PANSS)and clinical global impressions-secerity of illness rating scale of illness rating scale(CGL-SI),antipsychotic side effect was assessed by treatment emergent symptom scale(TESS),and rating scale for extrapyrarnidal side effects(RSESE)in 35 patients treated by aripiprazole(aripiprazole group)and 36 patients treated by haloperidol(hakioerudol group)for six weeks.Results The efficacy was similar in two groups.The reduction of total negative score in patients of aripiprazole group was significantly higher than that in haloperidol group after 4 and 6 weeks.Patients in aripiprazole group had significantly less side effects.Conclusion Aripiprazole is an effective and safe antipsychotic.

Key concepts: Aripiprazole, Haloperidol, Medicine, Schizophrenia (object-oriented programming), Rating scale, Antipsychotic, Antipsychotic Agent, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison study of aripiprazole and haloperidol in treatment of schizophrenia — Research Paper | ScholarLens